|Admission Document||Admission Document|
|Articles of Association||Articles of Association|
|Terms of Reference for AIM Compliance||Terms of Reference for AIM Compliance|
|Terms of Reference for Audit Committee||Terms of Reference for Audit Committee|
|Terms of Reference for Remuneration Committee||Terms of Reference for Remuneration Committee|
|Memorandum on Directors' Duties & Responsibilities||Memorandum on Directors' Duties & Responsibilities|
|Notice of AGM 2017||Notice of AGM 2017|
|Proxy Form 2017||Proxy Form 2017|
|Notice of AGM & Proxy Form 2016||Notice of AGM & Proxy Form 2016|
Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).
These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.
By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.